Director Hurlston sells 67,453 shares ($6.7M) across 8 transactions on 2024-11-27, reducing stake 41.7%; stock up 42.3% in 30d.
Michael E. Hurlston, Director at Astera Labs, executed 8 separate sales on 2024-11-27, totaling 67,453 shares for $6,732,931.81 at a blended average price of $99.82, reducing his holdings from 161,747 to 94,294 shares (41.7% reduction). The sales occurred during a period of significant upward momentum: the stock is up 42.3% over the prior 30 days and 164.4% over 90 days, though it trades 3.6% below its 52-week high of $107.31. This represents Hurlston's second open-market sale; his cross-ticker track record across all prior sells shows a 100.00% well-timed rate (negative average 90d return of -1.3%), suggesting historical accuracy in exit timing. The company's fundamentals show a net loss of $7.6M on quarterly revenue of $113.1M, providing context for market sentiment on operating performance relative to valuation.